Overexpression of CD157 contributes to epithelial ovarian cancer progression by promoting mesenchymal differentiation

PLoS ONE

Volumn 7, Issue 8, 2012, Pages

  Morone, Simona ^a   Lo Buono, Nicola ^a   Parrotta, Rossella ^a   Giacomino, Alice ^a   Nacci, Giulia ^a   Brusco, Alfredo ^a   Larionov, Alexey ^a   Ostano, Paola ^b   Mello Grand, Maurizia ^b   Chiorino, Giovanna ^b   Ortolan, Erika ^a   Funaro, Ada ^a  

^a UNIVERSITY OF TURIN   (Italy)

^b Laboratory of Cancer Genomics   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CD157 ANTIGEN; CELL MARKER; TRANSCRIPTOME;

ANCHORAGE INDEPENDENT GROWTH; ANOIKIS; APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CANCER GROWTH; CELL DISRUPTION; CELL INVASION; CELL JUNCTION; CELL MIGRATION; CELL MOTILITY; CELL SHAPE; CELL STRAIN; CELL STRAIN A2780; CELL STRAIN OV 90; CELL STRAIN OVCAR 3; CELL STRAIN TOV 21G; CELLULAR STRESS RESPONSE; CONTROLLED STUDY; DOWN REGULATION; GENE EXPRESSION PROFILING; GENE OVEREXPRESSION; GENETIC SELECTION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; MESENCHYME CELL; MESOTHELIUM CELL; OVARY CARCINOMA; PHENOTYPE; PROTEIN EXPRESSION; UPREGULATION;

ADP-RIBOSYL CYCLASE; ANTIGENS, CD; APOPTOSIS; BLOTTING, WESTERN; CELL ADHESION; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; FEMALE; GPI-LINKED PROTEINS; HUMANS; NEOPLASMS, GLANDULAR AND EPITHELIAL; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; OVARIAN NEOPLASMS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 84865165565     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0043649     Document Type: Article

References (53)

1. Bast RC Jr, Hennessy B, Mills GB, ((2009)) The biology of ovarian cancer: new opportunities for translation. Nature reviews Cancer 9:: 415--428.
2. Acloque H, Adams MS, Fishwick K, Bronner-Fraser M, Nieto MA, ((2009)) Epithelial-mesenchymal transitions: the importance of changing cell state in development and disease. J Clin Invest 119:: 1438--1449.
3. Thiery JP, Acloque H, Huang RY, Nieto MA, ((2009)) Epithelial-mesenchymal transitions in development and disease. Cell 139:: 871--890.
4. Polyak K, Weinberg RA, ((2009)) Transitions between epithelial and mesenchymal states: acquisition of malignant and stem cell traits. Nat Rev Cancer 9:: 265--273.
5. Ishihara K, Hirano T, ((2000)) BST-1/CD157 regulates the humoral immune responses in vivo. Chem Immunol 75:: 235--255.
6. Malavasi F, Deaglio S, Funaro A, Ferrero E, Horenstein AL, et al. ((2008)) Evolution and function of the ADP ribosyl cyclase/CD38 gene family in physiology and pathology. Physiol Rev 88:: 841--886.
7. Liang F, Qi RZ, Chang CF, ((2001)) Signalling of GPI-anchored CD157 via focal adhesion kinase in MCA102 fibroblasts. FEBS Lett 506:: 207--210.
8. Lavagno L, Ferrero E, Ortolan E, Malavasi F, Funaro A, ((2007)) CD157 is part of a supramolecular complex with CD11b/CD18 on the human neutrophil cell surface. J Biol Regul Homeost Agents 21:: 5--11.
9. Lo Buono N, Parrotta R, Morone S, Bovino P, Nacci G, et al. ((2011)) The CD157-integrin partnership controls transendothelial migration and adhesion of human monocytes. J Biol Chem 286:: 18681--18691.
10. Kaisho T, Ishikawa J, Oritani K, Inazawa J, Tomizawa H, et al. ((1994)) BST-1, a surface molecule of bone marrow stromal cell lines that facilitates pre-B-cell growth. Proc Natl Acad Sci U S A 91:: 5325--5329.
11. Goldstein SC, Todd RF 3rd ((1993)) Structural and biosynthetic features of the Mo5 human myeloid differentiation antigen. Tissue Antigens 41:: 214--218.
12. Funaro A, Ortolan E, Bovino P, Lo Buono N, Nacci G, et al. ((2009)) Ectoenzymes and innate immunity: the role of human CD157 in leukocyte trafficking. Front Biosci 14:: 929--943.
13. Ortolan E, Arisio R, Morone S, Bovino P, Lo-Buono N, et al. ((2010)) Functional Role and Prognostic Significance of CD157 in Ovarian Carcinoma. J Natl Cancer Inst 105:: 1160--1177.
14. Dull T, Zufferey R, Kelly M, Mandel RJ, Nguyen M, et al. ((1998)) A third-generation lentivirus vector with a conditional packaging system. J Virol 72:: 8463--8471.
15. Zecchini S, Bianchi M, Colombo N, Fasani R, Goisis G, et al. ((2008)) The differential role of L1 in ovarian carcinoma and normal ovarian surface epithelium. Cancer Res 68:: 1110--1118.
16. Chauhan SC, Vannatta K, Ebeling MC, Vinayek N, Watanabe A, et al. ((2009)) Expression and functions of transmembrane mucin MUC13 in ovarian cancer. Cancer Res 69:: 765--774.
17. Slack-Davis JK, Atkins KA, Harrer C, Hershey ED, Conaway M, ((2009)) Vascular cell adhesion molecule-1 is a regulator of ovarian cancer peritoneal metastasis. Cancer Res 69:: 1469--1476.
18. Ito A, Nakajima S, Sasaguri Y, Nagase H, Mori Y, ((1995)) Co-culture of human breast adenocarcinoma MCF-7 cells and human dermal fibroblasts enhances the production of matrix metalloproteinases 1, 2 and 3 in fibroblasts. Br J Cancer 71:: 1039--1045.
19. Legrand C, Polette M, Tournier JM, de Bentzmann S, Huet E, et al. ((2001)) uPA/plasmin system-mediated MMP-9 activation is implicated in bronchial epithelial cell migration. Exp Cell Res 264:: 326--336.
20. Chikh A, Matin RN, Senatore V, Hufbauer M, Lavery D, et al. ((2011)) iASPP/p63 autoregulatory feedback loop is required for the homeostasis of stratified epithelia. EMBO J 30:: 4261--4273.
21. Gentleman RC, Carey VJ, Bates DM, Bolstad B, Dettling M, et al. ((2004)) Bioconductor: open software development for computational biology and bioinformatics. Genome Biol 5:: R80.
22. Smyth GK, Michaud J, Scott HS, ((2005)) Use of within-array replicate spots for assessing differential expression in microarray experiments. Bioinformatics 21:: 2067--2075.
23. Huang da W, Sherman BT, Lempicki RA, ((2009)) Bioinformatics enrichment tools: paths toward the comprehensive functional analysis of large gene lists. Nucleic Acids Res 37:: 1--13.
24. Hamilton TC, Young RC, McKoy WM, Grotzinger KR, Green JA, et al. ((1983)) Characterization of a human ovarian carcinoma cell line (NIH:OVCAR-3) with androgen and estrogen receptors. Cancer Res 43:: 5379--5389.
25. Hamilton TC, Ozols RF, Longo DL, ((1987)) Biologic therapy for the treatment of malignant common epithelial tumors of the ovary. Cancer 60:: 2054--2063.
26. Yilmaz M, Christofori G, ((2009)) EMT, the cytoskeleton, and cancer cell invasion. Cancer Metastasis Rev 28:: 15--33.
27. Tang MK, Zhou HY, Yam JW, Wong AS, ((2010)) c-Met overexpression contributes to the acquired apoptotic resistance of nonadherent ovarian cancer cells through a cross talk mediated by phosphatidylinositol 3-kinase and extracellular signal-regulated kinase 1/2. Neoplasia 12:: 128--138.
28. Thiery JP, ((2002)) Epithelial-mesenchymal transitions in tumour progression. Nat Rev Cancer 2:: 442--454.
29. Kalluri R, Weinberg RA, ((2009)) The basics of epithelial-mesenchymal transition. J Clin Invest 119:: 1420--1428.
30. Zeisberg M, Neilson EG, ((2009)) Biomarkers for epithelial-mesenchymal transitions. J Clin Invest 119:: 1429--1437.
31. Sasaki CY, Lin H, Morin PJ, Longo DL, ((2000)) Truncation of the extracellular region abrogrates cell contact but retains the growth-suppressive activity of E-cadherin. Cancer Res 60:: 7057--7065.
32. Kwon Y, Cukierman E, Godwin AK, ((2011)) Differential expressions of adhesive molecules and proteases define mechanisms of ovarian tumor cell matrix penetration/invasion. PLoS One 6:: e18872.
33. Peinado H, Olmeda D, Cano A, ((2007)) Snail, Zeb and bHLH factors in tumour progression: an alliance against the epithelial phenotype? Nat Rev Cancer 7:: 415--428.
34. Cavallaro U, Christofori G, ((2004)) Cell adhesion and signalling by cadherins and Ig-CAMs in cancer. Nat Rev Cancer 4:: 118--132.
35. Bourboulia D, Stetler-Stevenson WG, ((2010)) Matrix metalloproteinases (MMPs) and tissue inhibitors of metalloproteinases (TIMPs): Positive and negative regulators in tumor cell adhesion. Semin Cancer Biol 20:: 161--168.
36. Sodek KL, Ringuette MJ, Brown TJ, ((2009)) Compact spheroid formation by ovarian cancer cells is associated with contractile behavior and an invasive phenotype. Int J Cancer 124:: 2060--2070.
37. Zietarska M, Maugard CM, Filali-Mouhim A, Alam-Fahmy M, Tonin PN, et al. ((2007)) Molecular description of a 3D in vitro model for the study of epithelial ovarian cancer (EOC). Mol Carcinog 46:: 872--885.
38. Simpson CD, Anyiwe K, Schimmer AD, ((2008)) Anoikis resistance and tumor metastasis. Cancer Lett 272:: 177--185.
39. Chaffer CL, Weinberg RA, ((2011)) A perspective on cancer cell metastasis. Science 331:: 1559--1564.
40. Ahmed N, Abubaker K, Findlay J, Quinn M, ((2010)) Epithelial mesenchymal transition and cancer stem cell-like phenotypes facilitate chemoresistance in recurrent ovarian cancer. Curr Cancer Drug Targets 10:: 268--278.
41. Wellner U, Schubert J, Burk UC, Schmalhofer O, Zhu F, et al. ((2009)) The EMT-activator ZEB1 promotes tumorigenicity by repressing stemness-inhibiting microRNAs. Nat Cell Biol 11:: 1487--1495.
42. Guadamillas MC, Cerezo A, Del Pozo MA, ((2011)) Overcoming anoikis- pathways to anchorage-independent growth in cancer. J Cell Sci 124:: 3189--3197.
43. Kessenbrock K, Plaks V, Werb Z, ((2010)) Matrix metalloproteinases: regulators of the tumor microenvironment. Cell 141:: 52--67.
44. Kenny HA, Lengyel E, ((2009)) MMP-2 functions as an early response protein in ovarian cancer metastasis. Cell Cycle 8:: 683--688.
45. Cowden Dahl KD, Symowicz J, Ning Y, Gutierrez E, Fishman DA, et al. ((2008)) Matrix metalloproteinase 9 is a mediator of epidermal growth factor-dependent e-cadherin loss in ovarian carcinoma cells. Cancer Res 68:: 4606--4613.
46. Davidson B, Goldberg I, Gotlieb WH, Kopolovic J, Ben-Baruch G, et al. ((2002)) The prognostic value of metalloproteinases and angiogenic factors in ovarian carcinoma. Mol Cell Endocrinol 187:: 39--45.
47. Yang S, Zhong C, Frenkel B, Reddi AH, Roy-Burman P, ((2005)) Diverse biological effect and Smad signaling of bone morphogenetic protein 7 in prostate tumor cells. Cancer Res 65:: 5769--5777.
48. Alarmo EL, Parssinen J, Ketolainen JM, Savinainen K, Karhu R, et al. ((2009)) BMP7 influences proliferation, migration, and invasion of breast cancer cells. Cancer Lett 275:: 35--43.
49. Lancaster JM, Dressman HK, Clarke JP, Sayer RA, Martino MA, et al. ((2006)) Identification of genes associated with ovarian cancer metastasis using microarray expression analysis. Int J Gynecol Cancer 16:: 1733--1745.
50. Ween MP, Oehler MK, Ricciardelli C, ((2011)) Role of Versican, Hyaluronan and CD44 in Ovarian Cancer Metastasis. Int J Mol Sci 12:: 1009--1029.
51. Munz M, Baeuerle PA, Gires O, ((2009)) The emerging role of EpCAM in cancer and stem cell signaling. Cancer Res 69:: 5627--5629.
52. Visvader JE, Lindeman GJ, ((2008)) Cancer stem cells in solid tumours: accumulating evidence and unresolved questions. Nat Rev Cancer 8:: 755--768.
53. Mani SA, Guo W, Liao MJ, Eaton EN, Ayyanan A, et al. ((2008)) The epithelial-mesenchymal transition generates cells with properties of stem cells. Cell 133:: 704--715.